Brendan Teehan, EVP, COO, Head of Commercial: Acadia Pharmaceuticals ACAD Sell · Filed 23/11/21

Trade details

Type: Insider sale
Amount: $112,294.4
Shares · price: 4,960 sh · $22.64 a share
Held after: 30,393 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Brendan TeehanEVP, COO, Head of Commercial
Trade date: 23/11/20
Filed: 23/11/21
Days to filing: 1 days

Sold 14.0% of holdings

Share of holding sold: 14.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

Brendan Teehan's recent trades

Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$173.6K
10,329 sh
$173.6K
Filed 24/11/19
Traded 24/11/19
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$145.7K
9,534 sh
$145.7K
Filed 24/08/20
Traded 24/08/19
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$58.9K
3,477 sh
$58.9K
Filed 24/05/03
Traded 24/05/02
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$45.9K
2,568 sh
$45.9K
Filed 24/04/09
Traded 24/04/08
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$92K
5,140 sh
$92K
Filed 24/03/27
Traded 24/03/27